Circular RNAs: Epigenetic regulators of PTEN expression and function in cancer

Mohammad-Mojtaba Farazi1, Saeideh Jafarinejad-Farsangi2, Zahra Miri Karam3

  • 1Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran.

Gene
|April 6, 2024
PubMed

Insights

Circular RNAs (circRNAs) are emerging epigenetic regulators influencing phosphatase and tensin homolog (PTEN) expression. Understanding circRNA-PTEN interactions offers new therapeutic avenues for cancer treatment.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Epigenetic regulation controls gene expression without altering DNA sequence, impacting cellular processes and diseases like cancer.
  • Epigenetics encompasses DNA methylation, histone modification, and regulatory non-coding RNAs (ncRNAs).
  • Circular RNAs (circRNAs) are a class of ncRNAs recently identified as significant epigenetic regulators.

Purpose of the Study:

  • To review the regulatory role of circRNAs in controlling phosphatase and tensin homolog (PTEN) expression.
  • To elucidate the function of PTEN, a crucial tumor suppressor, in cancer pathways.
  • To explore novel therapeutic strategies targeting circRNA-PTEN interactions in cancer.

Main Methods:

  • Literature review of studies on circRNAs and PTEN.
  • Analysis of circRNA regulation at transcriptional, post-transcriptional, translational, and post-translational levels.
  • Examination of the PI3K/AKT pathway's role in cancer and PTEN's involvement.

Main Results:

  • CircRNAs modulate PTEN expression through multiple regulatory mechanisms.
  • PTEN acts as a tumor suppressor by inhibiting the PI3K/AKT pathway, crucial for cancer cell proliferation and survival.
  • Significant research highlights the intricate relationship between circRNAs and PTEN in oncogenesis.

Conclusions:

  • CircRNAs represent a vital component of epigenetic regulation impacting PTEN.
  • Understanding circRNA-PTEN interactions is key to deciphering PTEN's tumor-suppressive functions.
  • Targeting circRNA-PTEN pathways holds promise for developing innovative cancer therapies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K